Silexion Therapeutics CORP (SLXNW) — DEFA14A Filings

All DEFA14A filings from Silexion Therapeutics CORP. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (3)

Silexion Therapeutics Files Proxy Materials — Aug 12, 2025 Risk: low
Silexion Therapeutics Corp. filed a Definitive Additional Materials proxy statement on August 12, 2025. The company, formerly known as Biomotion Sciences until
Silexion Therapeutics Files Proxy Statement — Jul 7, 2025 Risk: low
Silexion Therapeutics Corp filed a Definitive Additional Materials proxy statement on July 7, 2025. The company, formerly known as Biomotion Sciences until May
Silexion Therapeutics Files Proxy Materials — Jun 23, 2025 Risk: low
Silexion Therapeutics Corp filed a Definitive Additional Materials proxy statement on June 23, 2025. This filing relates to the company's proxy materials, indic

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX